A new cancer clinical trial by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) shows that a drug that utilizes the body's ...
To tailor cancer therapies to individual patients, Moderna, BioNTech and other companies are rethinking how they optimize ...
TAIPEI and SAN DIEGO, Oct. 21, 2025 /PRNewswire/ -- Senhwa Biosciences's investigational new drug Silmitasertib (CX-4945) was recently featured in an official post by Google DeepMind, following a ...
Breastfeeding comes with a slew of recognisd benefits, and now, new research suggests it may have a role in boosting women’s ...
Patients with late-stage lung and skin cancer may have just won an unlikely ally: the COVID-19 mRNA vaccine. Researchers at ...
La Jolla scientists at the La Jolla Institute for Immunology have made breakthroughs finding evidence that ALS could be an ...
The Edmonton Oilers' anthem singer who became a fan favourite for belting out O Canada in the stands with fans says he's ...
Barr virus (EBV), known for causing mononucleosis, might also be involved in triggering multiple sclerosis (MS). Recent ...
"mRNA cancer vaccines sensitize tumors to immune checkpoint inhibitors (ICIs) in part by stimulating a surge in inflammatory ...
Researchers at VIB and Ghent University have uncovered a key mechanism that protects the skin from harmful inflammation. The ...
Researchers have traced the earliest stages of multiple sclerosis (MS), showing that the immune system begins attacking the brain up to seven years before diagnosis.
Working with an international team of collaborators, scientists at Columbia University have found a way to shift the balance ...